Clinical Trial Update: Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of curcumin for the lower gastrointestinal tract in patients with familial adenomatous polyposis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Familial Adenomatous Polyposis | Phase 2 | Status: WITHDRAWN